ZEISS Showcases New CIRRUS 6000 OCT System at the European Society of Retina Specialists 2019 Congress

The ZEISS CIRRUS 6000, 100kHz OCT system promises to dramatically elevate the efficiency of eye care practices.

Paris, France | 05 September 2019 | Carl Zeiss Meditec AG

ZEISS Medical Technology Segment expands its *CIRRUS® — the most trusted Optical Coherence Tomography (OCT) with the launch of its new CIRRUS 6000, 100kHz ultra-fast OCT system that promises to dramatically elevate the efficiency of advanced care practices.

CIRRUS 6000 is the latest addition to an already robust portfolio of OCT devices that are designed to meet the needs of all types and levels of practices and/or clinicians. It offers customers high-speed and high-throughput to help manage their large patient volume faster, all while improving imaging and image quality.

“This system was designed with the patient in mind, enabling doctors to continue accessing their patient data from CIRRUS devices that are crucial to effective long-term patient care,” said Jim Mazzo, Global President of Ophthalmic Devices at Carl Zeiss Meditec. “We are committed to our customers and believe this will become an essential asset to their practice.”

The 100kHz speed of the CIRRUS 6000 allows clinicians to scan patients faster, with increased efficiency and improved imaging detail. Additional features include:

Press Contact

Laurie Ferguson
Head of Global Communications Ophthalmic Devices
Carl Zeiss Meditec Inc.
Phone: +1 925 560 5163
laurie .ferguson @zeiss .com

Contact for investors

Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220-116
investors .meditec @zeiss .com

ZEISS CIRRUS 6000
ZEISS CIRRUS 6000
  • Wider and deeper OCT/OCTA scans with 12x12mm OCTA and B-scan depth up to 2.9mm
  • HD AngioPlex scan is a new scan type that provides more detail
  • New workflow protocols to aid in increasing efficiency
  • Patient-friendly “Wellness report” to help educate the patient

According to retina and vitreoretinal physician and surgeon Gregg T. Kokame, MD, of Retina Consultants of Hawaii, the new ZEISS CIRRUS 6000 is extremely fast and impressive. “With the new scan acquisition time of 100,000 per second I can scan and assess my patients much quicker, giving me the details I need with every image,” says Kokame.

“ZEISS is dedicated to advancing eye care through development of new and innovative solutions, like the CIRRUS 6000,” said Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG. “With our comprehensive diagnostics portfolio, we will continue to create better vision standards to benefit patients today and in the future.”

During EURETINA, ZEISS will also showcase the CLARUS™ 700, Slit Lamp 800, PLEX® Elite and the ARTEVO® 800 along with the company’s other flagship devices at Booth 215.

 

*Not yet CE marked

Brief Profile

Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With approximately 3,050 employees worldwide, the Group generated revenue of €1,280.9m in fiscal year 2017/18 (to 30 September).

The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 41 percent of Carl Zeiss Meditec AG’s shares are in free float. The remaining approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.

For more information visit our website at www.zeiss.com/med

Press Contact

Laurie Ferguson
Head of Global Communications Ophthalmic Devices
Carl Zeiss Meditec Inc.
Phone: +1 925 560 5163
laurie .ferguson @zeiss .com

Contact for investors

Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220-116
investors .meditec @zeiss .com

Further Information
Share
Further Articles

2019 CCOS蔡司屈光精彩回顾

蔡司SMILE™手术的出现,让屈光手术进入了无瓣、微创的时代。今天全飞秒已在中国装机400台,SMILE™在中国手术量突破了120万例!感谢中国屈光专家及医师大力协作和努力,让SMILE™得到广大医生和患者的认可,造福了千万屈光不正患者。

2019-12-9

蔡司新技术研讨会

2019年9月4日,正值第24届全国眼科学术大会之际,在美丽的金鸡湖畔,蔡司一年一度的新技术研讨会盛大召开。本次会议荣幸地邀请到吴德正教授、高汝龙教授、许迅教授、徐格致教授、孙晓东教授、卢奕教授、严宏教授、张淳教授、陈有信教授、丁小燕...

2019-12-9

蔡司电影节,用光影点亮中国眼底病论坛

2019中国眼底病论坛暨国际视网膜研讨会(Retina China 2019)在上海顺利举行。蔡司电影节作为会议期间的人气活动,近30位眼科手术专家出席,超过2,000名眼科医生共同参与。

2019-5-4